Dystrophin Genotype–Cardiac Phenotype Correlations in Duchenne and Becker Muscular Dystrophies Using Cardiac Magnetic Resonance Imaging

American Journal of Cardiology

Volumn 115, Issue 7, 2015, Pages 967-971

  Tandon, Animesh ^a   Jefferies, John L ^a   Villa, Chet R ^a   Hor, Kan N ^b   Wong, Brenda L ^a   Ware, Stephanie M ^a   Gao, Zhiqian ^a   Towbin, Jeffrey A ^a   Mazur, Wojciech ^c   Fleck, Robert J ^a   Sticka, Joshua J ^a   Benson, D Woodrow ^d   Taylor, Michael D ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b NATIONWIDE CHILDREN S HOSPITAL   (United States)

^c CHRIST HOSPITAL   (United States)

^d CHILDREN S HOSPITAL OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CYSTEINE; DYSTROPHIN; GADOLINIUM CHELATE; DNA;

ADOLESCENT; ADULT; AMINO TERMINAL SEQUENCE; ARTICLE; BECKER MUSCULAR DYSTROPHY; CARBOXY TERMINAL SEQUENCE; CARDIOVASCULAR MAGNETIC RESONANCE; CHILD; COHORT ANALYSIS; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; EXON; GENOTYPE PHENOTYPE CORRELATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE FIBROSIS; HUMAN; INDEL MUTATION; LATE GADOLINIUM ENHANCEMENT; MAJOR CLINICAL STUDY; MALE; NONSENSE MUTATION; PRIORITY JOURNAL; PROTEIN DOMAIN; RETROSPECTIVE STUDY; CARDIOMYOPATHIES; COMPLICATION; FEMALE; GENE DELETION; GENETICS; METABOLISM; MUTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; PROCEDURES; SKELETAL MUSCLE; YOUNG ADULT;

ADOLESCENT; ADULT; CARDIOMYOPATHIES; CHILD; CHILD, PRESCHOOL; DNA; DNA MUTATIONAL ANALYSIS; DYSTROPHIN; EXONS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE IMAGING, CINE; MALE; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; MUTATION; SEQUENCE DELETION; YOUNG ADULT;

EID: 85027944190     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2015.01.030     Document Type: Article

References (28)

1. Muntoni, F., Torelli, S., Ferlini, A., Dystrophin and mutations: one gene, several proteins, multiple phenotypes. Lancet Neurol 2 (2003), 731–740.
2. Finsterer, J., Stollberger, C., The heart in human dystrophinopathies. Cardiology 99 (2003), 1–19.
3. Connuck, D.M., Sleeper, L.A., Colan, S.D., Cox, G.F., Towbin, J.A., Lowe, A.M., Wilkinson, J.D., Orav, E.J., Cuniberti, L., Salbert, B.A., Lipshultz, S.E., Pediatric Cardiomyopathy Registry Study Group. Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the Pediatric Cardiomyopathy Registry. Am Heart J 155 (2008), 998–1005.
4. Jefferies, J.L., Eidem, B.W., Belmont, J.W., Craigen, W.J., Ware, S.M., Fernbach, S.D., Neish, S.R., Smith, E.O., Towbin, J.A., Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy. Circulation 112 (2005), 2799–2804.
5. Monaco, A.P., Bertelson, C.J., Liechti-Gallati, S., Moser, H., Kunkel, L.M., An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics 2 (1988), 90–95.
6. Flanigan, K.M., Dunn, D.M., von Niederhausern, A., Soltanzadeh, P., Gappmaier, E., Howard, M.T., Sampson, J.B., Mendell, J.R., Wall, C., King, W.M., Pestronk, A., Florence, J.M., Connolly, A.M., Mathews, K.D., Stephan, C.M., Laubenthal, K.S., Wong, B.L., Morehart, P.J., Meyer, A., Finkel, R.S., Bonnemann, C.G., Medne, L., Day, J.W., Dalton, J.C., Margolis, M.K., Hinton, V.J., United Dystrophinopathy Project Consortium, Weiss, R.B., Mutational spectrum of DMD mutations in dystrophinopathy patients: application of modern diagnostic techniques to a large cohort. Hum Mutat 30 (2009), 1657–1666.
7. Tuffery-Giraud, S., Beroud, C., Leturcq, F., Yaou, R.B., Hamroun, D., Michel-Calemard, L., Moizard, M.P., Bernard, R., Cossee, M., Boisseau, P., Blayau, M., Creveaux, I., Guiochon-Mantel, A., de Martinville, B., Philippe, C., Monnier, N., Bieth, E., Khau Van Kien, P., Desmet, F.O., Humbertclaude, V., Kaplan, J.C., Chelly, J., Claustres, M., Genotype-phenotype analysis in 2,405 patients with a dystrophinopathy using the UMD-DMD database: a model of nationwide knowledgebase. Hum Mutat 30 (2009), 934–945.
8. Kaspar, R.W., Allen, H.D., Ray, W.C., Alvarez, C.E., Kissel, J.T., Pestronk, A., Weiss, R.B., Flanigan, K.M., Mendell, J.R., Montanaro, F., Analysis of dystrophin deletion mutations predicts age of cardiomyopathy onset in Becker muscular dystrophy. Circ Cardiovasc Genet 2 (2009), 544–551.
9. Cohen, N., Muntoni, F., Multiple pathogenetic mechanisms in X linked dilated cardiomyopathy. Heart 90 (2004), 835–841.
10. Magri, F., Govoni, A., D'Angelo, M.G., Del Bo, R., Ghezzi, S., Sandra, G., Turconi, A.C., Sciacco, M., Ciscato, P., Bordoni, A., Tedeschi, S., Fortunato, F., Lucchini, V., Bonato, S., Lamperti, C., Coviello, D., Torrente, Y., Corti, S., Moggio, M., Bresolin, N., Comi, G.P., Genotype and phenotype characterization in a large dystrophinopathic cohort with extended follow-up. J Neurol 258 (2011), 1610–1623.
11. Deburgrave, N., Daoud, F., Llense, S., Barbot, J.C., Recan, D., Peccate, C., Burghes, A.H., Beroud, C., Garcia, L., Kaplan, J.C., Chelly, J., Leturcq, F., Protein- and mRNA-based phenotype-genotype correlations in DMD/BMD with point mutations and molecular basis for BMD with nonsense and frameshift mutations in the DMD gene. Hum Mutat 28 (2007), 183–195.
12. Diegoli, M., Grasso, M., Favalli, V., Serio, A., Gambarin, F.I., Klersy, C., Pasotti, M., Agozzino, E., Scelsi, L., Ferlini, A., Febo, O., Piccolo, G., Tavazzi, L., Narula, J., Arbustini, E., Diagnostic work-up and risk stratification in X-linked dilated cardiomyopathies caused by dystrophin defects. J Am Coll Cardiol 58 (2011), 925–934.
13. Carsana, A., Frisso, G., Tremolaterra, M.R., Lanzillo, R., Vitale, D.F., Santoro, L., Salvatore, F., Analysis of dystrophin gene deletions indicates that the hinge III region of the protein correlates with disease severity. Ann Hum Genet 69 (2005), 253–259.
14. Ferlini, A., Sewry, C., Melis, M.A., Mateddu, A., Muntoni, F., X-linked dilated cardiomyopathy and the dystrophin gene. Neuromuscul Disord 9 (1999), 339–346.
15. Birnkrant, D.J., Ashwath, M.L., Noritz, G.H., Merrill, M.C., Shah, T.A., Crowe, C.A., Bahler, R.C., Cardiac and pulmonary function variability in Duchenne/Becker muscular dystrophy: an initial report. J Child Neurol 25 (2010), 1110–1115.
16. Ashwath, M.L., Jacobs, I.B., Crowe, C.A., Ashwath, R.C., Super, D.M., Bahler, R.C., Left ventricular dysfunction in Duchenne muscular dystrophy and genotype. Am J Cardiol 114 (2014), 284–289.
17. White, S.J., den Dunnen, J.T., Copy number variation in the genome; the human DMD gene as an example. Cytogenet Genome Res 115 (2006), 240–246.
18. Aartsma-Rus, A., Van Deutekom, J.C., Fokkema, I.F., Van Ommen, G.J., Den Dunnen, J.T., Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confirm the reading-frame rule. Muscle Nerve 34 (2006), 135–144.
19. Nicolas, A., Lucchetti-Miganeh, C., Yaou, R.B., Kaplan, J.C., Chelly, J., Leturcq, F., Barloy-Hubler, F., Le Rumeur, E., Assessment of the structural and functional impact of in-frame mutations of the DMD gene, using the tools included in the eDystrophin online database. Orphanet J Rare Dis, 7, 2012, 45.
20. Hagenbuch, S.C., Gottliebson, W.M., Wansapura, J., Mazur, W., Fleck, R., Benson, D.W., Hor, K.N., Detection of progressive cardiac dysfunction by serial evaluation of circumferential strain in patients with Duchenne muscular dystrophy. Am J Cardiol 105 (2010), 1451–1455.
21. Hor, K.N., Wansapura, J., Markham, L.W., Mazur, W., Cripe, L.H., Fleck, R., Benson, D.W., Gottliebson, W.M., Circumferential strain analysis identifies strata of cardiomyopathy in Duchenne muscular dystrophy: a cardiac magnetic resonance tagging study. J Am Coll Cardiol 53 (2009), 1204–1210.
22. Mazur, W., Hor, K.N., Germann, J.T., Fleck, R.J., Al-Khalidi, H.R., Wansapura, J.P., Chung, E.S., Taylor, M.D., Jefferies, J.L., Woodrow Benson, D., Gottliebson, W.M., Patterns of left ventricular remodeling in patients with Duchenne muscular dystrophy: a cardiac MRI study of ventricular geometry, global function, and strain. Int J Cardiovasc Imaging 28 (2012), 99–107.
23. Fairclough, R.J., Wood, M.J., Davies, K.E., Therapy for Duchenne muscular dystrophy: renewed optimism from genetic approaches. Nat Rev Genet 14 (2013), 373–378.
24. Vainzof, M., Takata, R.I., Passos-Bueno, M.R., Pavanello, R.C., Zatz, M., Is the maintenance of the C-terminus domain of dystrophin enough to ensure a milder Becker muscular dystrophy phenotype?. Hum Mol Genet 2 (1993), 39–42.
25. Puchalski, M.D., Williams, R.V., Askovich, B., Sower, C.T., Hor, K.H., Su, J.T., Pack, N., Dibella, E., Gottliebson, W.M., Late gadolinium enhancement: precursor to cardiomyopathy in Duchenne muscular dystrophy?. Int J Cardiovasc Imaging 25 (2009), 57–63.
26. Walcher, T., Steinbach, P., Spiess, J., Kunze, M., Gradinger, R., Walcher, D., Bernhardt, P., Detection of long-term progression of myocardial fibrosis in Duchenne muscular dystrophy in an affected family: a cardiovascular magnetic resonance study. Eur J Radiol 80 (2011), 115–119.
27. Bushby, K., Finkel, R., Birnkrant, D.J., Case, L.E., Clemens, P.R., Cripe, L., Kaul, A., Kinnett, K., McDonald, C., Pandya, S., Poysky, J., Shapiro, F., Tomezsko, J., Constantin, C., DMD Care Considerations Working Group. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol 9 (2010), 77–93.
28. Hor, K.N., Mazur, W., Taylor, M.D., Al-Khalidi, H.R., Cripe, L.H., Jefferies, J.L., Raman, S.V., Chung, E.S., Kinnett, K.J., Williams, K., Gottliebson, W.M., Benson, D.W., Effects of steroids and angiotensin converting enzyme inhibition on circumferential strain in boys with Duchenne muscular dystrophy: a cross-sectional and longitudinal study utilizing cardiovascular magnetic resonance. J Cardiovasc Magn Reson, 13, 2011, 60.